Cambridge Institute of Therapeutic Immunology & Infectious DiseaseAs a component of our COVID research we conducted a seroepidemiology study to measure exposure to SARS-CoV-2 at Addenbrookes hospital. The work was lead by Dr Daniel Cooper, Dr Sara Lear, Prof Ian Goodfellow and Prof Stephen Baker in collaboration between the Hospital and the University. The work, A prospective study of risk factors associated […]
Upgrading PPE for staff working on COVID-19 wards cut hospital-acquired infections dramatically
Key mutations in Alpha variant enable SARS-CoV-2 to overcome evolutionary weak points
Ravi Gupta elected to the Academy of Medical Sciences
Single-cell transcriptomics and proteomics profiling of COVID19 samples reveals immune and HSPC changes that are differentially associated with disease severity
Infographics and risk factors associated with seroprevalence of SARS-CoV-2 antibodies in HCWs
Genomics study identifies routes of transmission of coronavirus in care homes
Department of Medicine Scientists launch a pre-emptive strike on deadly post-transplant infection
Dr Ian Groves The Wills/Sinclair group have just published on a potential new treatment to protect immunosuppressed patients from human cytomegalovirus (HCMV) in PNAS. This study shows that certain epigenetic inhibitors expose and help to destroy dormant HCMV infections, which often reactivate to cause serious illness and death in these vulnerable groups. Subject to clinical […]
Lab-grown ‘mini-bile ducts’ used to repair human livers in regenerative medicine first
Cambridge Festival trailer – Dr Giles Yeo
- 1
- 2
- 3
- 4
- Next Page »
